POLIFARMA SpA

Discover POLIFARMA SpA: Italian pharmaceutical excellence

POLIFARMA SpA is an Italian pharmaceutical company founded in 1919, based in Rome. In June 1999, it was acquired by the Final group, owned by Mrs. Luisa Angelini, one of the most influential figures in the Italian pharmaceutical market. With over a century of experience, POLIFARMA SpA stands out for its constant commitment to research and development of innovative therapeutic solutions, improving patients' quality of life.

Innovation and quality: the philosophy of POLIFARMA SpA

POLIFARMA SpA specializes in the production and commercialization of medicines, medical devices, and dietary supplements, with a focus on therapeutic areas such as Cardiology, Gastroenterology, Central Nervous System, and Ophthalmology. The company is committed to innovation, particularly in the development of Digital Therapeutics, and has acquired 100% of the German Hennig Arzneimittel, expanding its international presence.

Product range and competitive advantages

POLIFARMA SpA offers a wide range of products, including medications for the treatment of dizziness, medical devices, and dietary supplements. The acquisition of Hennig Arzneimittel has further enriched the portfolio, including neurological and psychiatric drugs. The company is ISO 9001:2015 certified, demonstrating its commitment to quality and efficiency in business processes.